Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 6/20 | 0.43 |
| ▸ | CXCL10 | P02778 | 1/20 | 0.39 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.39 |
| ▸ | CCL2 | P13500 | 1/20 | 0.39 |
| ▸ | CCL5 | P13501 | 1/20 | 0.39 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.39 |
| ▸ | M6PR | P20645 | 2/20 | 0.38 |
| ▸ | SERPINC1 | P01008 | 2/20 | 0.37 |
| ▸ | FGF1 | P05230 | 2/20 | 0.36 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.35 |
| ▸ | BDNF | P23560 | 3/20 | 0.35 |
| ▸ | PTN | P21246 | 2/20 | 0.35 |
| ▸ | MDK | P21741 | 2/20 | 0.35 |
| ▸ | G6PD | P11413 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12901064 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20363815 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL14030121 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20370858 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12755226 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL20363547 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12878540 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL12384884 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL22139521 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 | |
| SCHEMBL18309852 | 1.00 | F10 (0.43) | F10CXCL10CXCL8CCL2CCL5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9358203-B2 | Multi-purpose cosmetic compositions | MARY KAY INC. (US) | 2016-06-07 | — | — | US | disclosed |
| US-20160136086-A1 | COSMETIC FORMULATION | MARY KAY INC. | 2016-05-19 | — | — | US | disclosed |
| US-9320702-B2 | Multi-Purpose cosmetic compositions | MARY KAY INC. (US) | 2016-04-26 | — | — | US | disclosed |
| US-20140328958-A1 | Multi-Purpose Cosmetic Compositions | ALLUSTRA TECHNOLOGIES LLC | 2014-11-06 | — | — | US | disclosed |
| US-8877259-B2 | Cosmetic formulation | MARY KAY INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8759282-B2 | Water-soluble films comprising low-viscosity alginates | UPPSALAGRUPPEN MEDICAL AB (SE) | 2014-06-24 | — | — | US | disclosed |
| US-20130209504-A1 | COSMETIC FORMULATION | MARY KAY INC. (US) | 2013-08-15 | — | — | US | disclosed |
| US-20120237540-A1 | Multi-Purpose Cosmetic Compositions | MARY KAY INC. (US) | 2012-09-20 | — | — | US | disclosed |
| US-20100087550-A1 | Formulations with a Tertiary Amine Oxide | BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) | 2010-04-08 | — | — | US | disclosed |
| US-20090221489-A1 | Water-Soluable Films Comprising Low-Viscosity Alginates | EXCELLENS TECH. PRODUCTS APS (DK) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160136086-A1 | COSMETIC FORMULATION | CUTA, SYMPK, SGMS1 | F10 2528/4885CXCL10 1881/4885CXCL8 1269/4885 |
| US-20120237540-A1 | Multi-Purpose Cosmetic Compositions | BMI1, CUTA, LPO | F10 4194/4885CXCL10 2214/4885CXCL8 1909/4885 |
| US-20140328958-A1 | Multi-Purpose Cosmetic Compositions | BMI1, CUTA, LPO | F10 4194/4885CXCL10 2214/4885CXCL8 1909/4885 |
| US-20130209504-A1 | COSMETIC FORMULATION | SGMS1, SGMS2, CHKB | F10 2635/4885CXCL10 1520/4885CXCL8 1938/4885 |
| US-20100087550-A1 | Formulations with a Tertiary Amine Oxide | C1S, C1R, C5 | F10 427/4885CXCL10 2431/4885CXCL8 3533/4885 |
| US-20090221489-A1 | Water-Soluable Films Comprising Low-Viscosity Alginates | ALG1, SMARCA2, MUC1 | F10 203/4885CXCL10 4608/4885CXCL8 3308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.